● Recruiting

A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers

Condition: Obesity & Overweight · Type 2 Diabetes · Sponsor: Daewoong Pharmaceutical Co. LTD.

PhasePhase 1

Planned participants72

Who can joinAll sexes, 19 Years to 64 Years

Healthy volunteersYes

About this study

Phase 1 Safety and Relative Bioavailability Study of DWRX5003 in Healthy Adults

This description comes directly from the study's public registry record.

Talk to the study team

YeaRa Kwak · +8225508317 · yeara.kwak@daewoong.co.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National University Hospital

Seoul, South Korea

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07539415